Immuno- cell therapy in patients with metastatic breast cancer
Phase 1
Recruiting
- Conditions
- patients with metastatic breast cancer.Malignant neoplasm of breast
- Registration Number
- IRCT20240610062069N1
- Lead Sponsor
- omid cell and tissue processing company
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 6
Inclusion Criteria
patients with metastatic breast cancer
written informed consent form
Exclusion Criteria
Pregnant or breastfeeding women
Infected with HIV, HBV,HCV
Using immune suppressor drugs
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method